Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice

Abstract

Since no significant differences were observed in the pharmacokinetics of paclitaxel in sensitive and resistant tumor cell lines, the efficacy of this agent seemed to depend on the sensitivity of tumor cells rather than the intratumoral concentration of agent.